MicroRNA-153 is a prognostic marker and inhibits cell migration and invasion by targeting SNAI1 in human pancreatic ductal adenocarcinoma
Open Access
- 11 June 2015
- journal article
- retracted article
- Published by Spandidos Publications in Oncology Reports
- Vol. 34 (2) , 595-602
Abstract
Human pancreatic ductal adenocarcinoma (PDAC) is an aggressive cancer type with early metastasis, which leads to poor prognosis for patients. Mounting evidence suggests that microRNAs (miRNAs) act as critical factors for tumor recurrence and metastasis. miR-153 has been suggested as a novel tumor-associated miRNA, which is involved in tumor metastasis. However, the clinical significance of miR-153 and its role in PDAC remains to be investigated. The aim of the present study was to investigate the expression levels of miR-153 using RT-qPCR in human PDAC cell lines and tissues. A clinical association analysis was performed to investigate the clinical significance of miR-153. The results showed that, the relative expression of miR-153 in PDAC cells was obviously decreased as compared to that in the normal human pancreatic duct epithelial cell line. The mean expression of miR-153 in PDAC tissues was significantly reduced as compared to that in the normal pancreatic tissues. The clinical analysis revealed that a low expression of miR-153 was closely associated with poor prognostic features and shorter long-term survival of PDAC patients. Furthermore, univariate and multivariate Cox regression analyses showed that miR-153 was an independent prognostic factor for predicting survival in PDAC patients. In vitro studies demonstrated that the upregulation of miR-153 inhibited migration and invasion in MIAPaCa-2 cells. By contrast, the downregulation of miR-153 increased the number of migrated and invaded AsPC-1 cells. miR-153 inversely regulated SNAI1 abundance in MIAPaCa-2 cells. Notably, SNAI1 was identified as a direct target of miR-153 in PDAC. Furthermore, an inverse correlation between miR-153 and SNAI1 expression was observed in PDAC tissues. In conclusion, the results showed miR-153 is an independent prognostic marker for predicting survival in PDAC patients and inhibits cell migration and invasion by targeting SNAI1.Keywords
This publication has 28 references indexed in Scilit:
- Olea europaea leaf extract improves the treatment response of GBM stem cells by modulating miRNA expression.2014
- microRNA Expression Pattern Modulates Temozolomide Response in GBM Tumors with Cancer Stem CellsCellular and Molecular Neurobiology, 2014
- Targeting apoptosis pathways in pancreatic cancerCancer Letters, 2013
- MicroRNA-153 is tumor suppressive in glioblastoma stem cellsMolecular Biology Reports, 2013
- Olea europaea leaf extract alters microRNA expression in human glioblastoma cellsJournal of Cancer Research and Clinical Oncology, 2012
- Current Progress on Understanding MicroRNAs in Glioblastoma MultiformeGenes & Cancer, 2012
- Improvement in Treatment and Outcome of Pancreatic Ductal Adenocarcinoma in North ChinaJournal of Gastrointestinal Surgery, 2011
- Chromatin‐modifying drugs induce miRNA‐153 expression to suppress Irs‐2 in glioblastoma cell linesInternational Journal of Cancer, 2011
- Deregulation of miR‐519a, 153, and 485‐5p and its clinicopathological relevance in ovarian epithelial tumoursHistopathology, 2010
- Downregulations of B‐cell lymphoma 2 and myeloid cell leukemia sequence 1 by microRNA 153 induce apoptosis in a glioblastoma cell line DBTRG‐05MGInternational Journal of Cancer, 2009